Wall Street is positive on CytomX Therapeutics Inc (CTMX). On average, analysts give the stock a Hold rating. The average price target is $2.408, which means analysts expect the stock to increase by 75.77% over the next twelve months.
That average ranking earns the stock an Analyst Rating of 3, which is better than 3% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating CTMX a Hold today. Find out what this means to you and get the rest of the rankings on CTMX!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With CytomX Therapeutics Inc Stock Today?
CytomX Therapeutics Inc (CTMX) stock is trading at $1.37 as of 1:27 PM on Wednesday, Nov 29, an increase of $0.02, or 1.48% from the previous closing price of $1.35. The stock has traded between $1.35 and $1.41 so far today. Volume today is 199,295 compared to average volume of 198,021.
Click Here to get the full Stock Report for CytomX Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
